1. Home
  2. SLGL vs INHD Comparison

SLGL vs INHD Comparison

Compare SLGL & INHD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SLGL
  • INHD
  • Stock Information
  • Founded
  • SLGL 1997
  • INHD 2019
  • Country
  • SLGL Israel
  • INHD United States
  • Employees
  • SLGL N/A
  • INHD N/A
  • Industry
  • SLGL Biotechnology: Pharmaceutical Preparations
  • INHD
  • Sector
  • SLGL Health Care
  • INHD
  • Exchange
  • SLGL Nasdaq
  • INHD Nasdaq
  • Market Cap
  • SLGL 19.3M
  • INHD 19.8M
  • IPO Year
  • SLGL 2018
  • INHD 2023
  • Fundamental
  • Price
  • SLGL $13.00
  • INHD $1.20
  • Analyst Decision
  • SLGL Buy
  • INHD
  • Analyst Count
  • SLGL 1
  • INHD 0
  • Target Price
  • SLGL $40.00
  • INHD N/A
  • AVG Volume (30 Days)
  • SLGL 13.9K
  • INHD 312.9K
  • Earning Date
  • SLGL 08-15-2025
  • INHD 07-28-2025
  • Dividend Yield
  • SLGL N/A
  • INHD N/A
  • EPS Growth
  • SLGL N/A
  • INHD N/A
  • EPS
  • SLGL N/A
  • INHD N/A
  • Revenue
  • SLGL $12,103,000.00
  • INHD $2,600,163.00
  • Revenue This Year
  • SLGL N/A
  • INHD N/A
  • Revenue Next Year
  • SLGL $31.17
  • INHD N/A
  • P/E Ratio
  • SLGL N/A
  • INHD N/A
  • Revenue Growth
  • SLGL 603.66
  • INHD 656.40
  • 52 Week Low
  • SLGL $3.34
  • INHD $1.11
  • 52 Week High
  • SLGL $16.50
  • INHD $19.78
  • Technical
  • Relative Strength Index (RSI)
  • SLGL 87.12
  • INHD 32.80
  • Support Level
  • SLGL $10.95
  • INHD $1.15
  • Resistance Level
  • SLGL $12.90
  • INHD $1.51
  • Average True Range (ATR)
  • SLGL 1.12
  • INHD 0.09
  • MACD
  • SLGL 0.40
  • INHD -0.00
  • Stochastic Oscillator
  • SLGL 95.73
  • INHD 13.51

About SLGL Sol-Gel Technologies Ltd.

Sol-Gel Technologies Ltd is a dermatology company. It is engaged in identifying, developing and commercializing branded and generic topical drug products for the treatment of skin diseases. The company's product candidate pipeline includes SGT-610 (Patidegib Gel 2%), a new chemical entity hedgehog signaling pathway blocker, for the chronic use and prevention of new BCC in Gorlin syndrome patients, and the topical drug candidate SGT-210 for the treatment of Darier Disease and other rare keratosis-related indications such as PC, PPK and Olmsted.

About INHD Inno Holdings Inc.

Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.

Share on Social Networks: